28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 261 / 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02489500 (ClinicalTrials.gov)	June 2015	9/3/2015	Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib	Phase III Trial of High-dose Melphalan and Stem Cell Transplantation Versus High-dose Melphalan and ...	AL Amyloidosis	Drug: Bortezomib;Drug: Melphalan;Drug: Neupogen;Procedure: Stem Cell Collection;Procedure: Stem cell ...	Boston Medical Center	NULL	Terminated	18 Years	N/A	All	3	Phase 3	United States
2	NCT00790647 (ClinicalTrials.gov)	June 2008	12/11/2008	Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidos ...	Phase II Trial of High-dose Melphalan and Bortezomib and Stem Cell Transplantation in Patients With ...	Multiple Myeloma	Biological: filgrastim;Drug: bortezomib;Drug: melphalan;Procedure: Stem Cell Infusion	Boston Medical Center	NULL	Completed	18 Years	65 Years	All	10	Phase 2	United States
3	NCT00075608 (ClinicalTrials.gov)	August 2001	9/1/2004	2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis	Phase II Trial of Second Autologous Transplantation in AL Amyloidosis	Multiple Myeloma;Plasma Cell Neoplasm	Biological: filgrastim;Drug: melphalan;Procedure: autologous stem cell transplantation;Procedure: st ...	Boston Medical Center	NULL	Terminated	18 Years	65 Years	All	12	Phase 2	United States

First Previous1Next Last